Independence Bank of Kentucky lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,310 shares of the healthcare conglomerate's stock after selling 2,365 shares during the period. Independence Bank of Kentucky's holdings in UnitedHealth Group were worth $4,352,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. Financial Management Professionals Inc. increased its holdings in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after buying an additional 17 shares during the last quarter. Richwood Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares during the period. Prentice Wealth Management LLC increased its position in UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after buying an additional 21 shares in the last quarter. Finally, 44 Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Up 2.5%
Shares of UNH stock opened at $303.24 on Friday. The company has a market cap of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock's 50 day simple moving average is $409.03 and its two-hundred day simple moving average is $484.21. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the firm earned $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.
Wall Street Analyst Weigh In
A number of research firms have weighed in on UNH. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Raymond James downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $428.43.
View Our Latest Research Report on UnitedHealth Group
Insider Transactions at UnitedHealth Group
In related news, Director John H. Noseworthy bought 300 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO John F. Rex purchased 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report